Intel has unveiled its pitch to become the organization that pulls cancer data out of silos. The semiconductor giant has spent the past two years working on the problem with Oregon Health & Science University, bringing it to the point at which it is ready to open up the platform to other organizations.
BioClinica has expanded the range of ways customers can access its suite of eClinical tools. The new service, dubbed the BioClinica eHealth Cloud, allows biopharma companies and CROs to run Express EDC, Trident RTSM and other pieces of trial software on public, private, managed or custom cloud infrastructure.
The battlefront between Amazon and Google covers a diverse range of fields, from online search and advertising, to smartphones and shopping. Increasingly, genomics is emerging as another hotspot, with both companies scrambling to establish themselves as the place to store and analyze DNA data.
Agilent Technologies has struck a deal to acquire Cartagenia. The buyout will give Agilent software to interpret clinical genomics data, an asset it plans to offer to its molecular oncology customers.
Medidata has connected its Clinical Cloud to Apple's ResearchKit. The link means researchers can feed data gathered by ResearchKit apps into Medidata's cloud platform, where the information can be integrated with other sources of clinical trial results.
AstraZeneca is extending its use of Elixir Software's R&D workflow-management software, in part to support communication while it is moving its focal point in the United Kingdom from Alderley Park to Cambridge.
Box has added a big-name client just days after pulling off a $175 million IPO. The deal sees AstraZeneca join Allergan and Eli Lilly on the list of major biopharma companies that use Box's cloud content sharing and collaboration tools.
Flatiron Health has revealed part of how it plans to develop into the disruptive force in cancer drug R&D that investors envisaged when they gave it $130 million in May. The latest piece of the plan is a deal with testing firm Foundation Medicine, which will contribute genomic profiling data to a cancer analytics platform.
Microsoft has taken a lead from its co-founder Bill Gates' philanthropic efforts. The computing giant is making its Azure cloud platform available to Ebola researchers who need help with the storage and analysis of data.
Faced with the challenge of how to handle data from the 100,000 exomes it intends to sequence, Regeneron has struck a deal with DNAnexus to access cloud-based infrastructure.The biotech is working with DNAnexus through the Regeneron Genetics Center it established for the sequencing project.